Related Experiment Video

Updated: Apr 11, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

18.1K

How to Treat Obstructions in Patients with Hypertrophic Cardiomyopathy

Josef Veselka1

  • 1Department of Cardiology, Motol University Hospital, Prague, Czech Republic.

The International Journal of Angiology : Official Publication of the International College of Angiology, Inc
|June 11, 2015
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) involves thickened heart walls, often causing left ventricular obstruction. Treatment decisions for obstructive HCM, like alcohol septal ablation or surgical myectomy, are individualized.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine

Background:

  • Hypertrophic cardiomyopathy (HCM) is defined by left ventricular wall thickening not due to abnormal loading conditions.
  • A significant proportion of HCM patients (two-thirds) develop left ventricular outflow tract obstruction, at rest or with provocation.
  • This obstruction correlates with increased symptom burden and poorer patient prognosis.

Purpose of the Study:

  • To review and compare the primary invasive therapeutic strategies for obstructive hypertrophic cardiomyopathy (oHCM).
  • To highlight the current approaches for managing left ventricular obstruction in HCM patients.

Main Methods:

  • Discussion of alcohol septal ablation as a treatment option for obstructive HCM.
  • Discussion of surgical myectomy as a treatment option for obstructive HCM.

Main Results:

  • Both alcohol septal ablation and surgical myectomy are established interventions for obstructive HCM.
  • Individualized patient assessment is crucial for selecting the optimal invasive therapy.

Conclusions:

  • The choice between alcohol septal ablation and surgical myectomy for obstructive HCM requires careful consideration of patient-specific factors.
  • Personalized treatment planning, considering patient wishes, lifestyle, age, cardiac morphology, hemodynamics, and institutional expertise, is paramount for optimal outcomes in obstructive HCM.

Keywords:
alcohol septal ablationhypertrophic cardiomyopathysurgical myectomy

More Related Videos

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

7.1K
O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy09:24

O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy

Published on: October 6, 2022

4.5K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
681
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
754
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
435
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
786
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
481
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
599